AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 3, 2008). doi:10.1152/ajpheart.91436.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/H543    most recent
91436.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajagopalan, V.
Right arrow Articles by Ma, Y. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajagopalan, V.
Right arrow Articles by Ma, Y. J
Submitted on December 12, 2007
Revised on May 12, 2008
Accepted on May 27, 2008

Cardiac ErbB-1/ErbB-2 Mutant Expression In Young Adult Mice Leads to Cardiac Dysfunction

Viswanathan Rajagopalan1*, Irving H. Zucker2, Jocelyn A Jones1, Michaela Carlson1, and Ying J Ma

1 UNIVERSITY OF NEBRASKA MEDICAL CENTER
2 University of Nebraska Medical Ctr, Theodore F. Hubbard Professor of Cardiovascular Research

* To whom correspondence should be addressed. E-mail: vrajagop{at}unmc.edu.

Aims: Multiple factors lead to the development and maintenance of chronic heart failure. Blockade of ErbB-2 or ErbB-4 tyrosine kinase receptor signaling leads to dilated cardiomyopathy. ErbB-1 may protect the heart against stress-induced injury and its ligand, epidermal growth factor (EGF) increases myocardial contractility while heparin-binding EGF is essential for normal cardiac function. However, the role of ErbB-1 in control of cardiac function is not clear. We hypothesized that ErbB-1 is essential for maintaining adult cardiac function. Methods: Using ecdysone inducible gene expression system, we expressed cardiomyocyte-specific dominant-negative ErbB-1 mutant receptors (hErbB-1-mut) in young adult mice that block endogenous cardiac ErbB-1 signaling. Molecular, morphological and physiological tests (under anesthesia) were performed. Results: hErbB-1-mut was expressed selectively in cardiomyocytes leading to blockade of endogenous ErbB-1 phosphorylation and ErbB-2 transphosphorylation. Increase in left ventricular mass, atrial natriuretic factor expression and histological changes were indicative of cardiac hypertrophy. Cardiac dilation, numerous cardiac lesions and loss of clear boundary between cardiac fibrils were noted histologically. Early and long-term hErbB-1-mut induction led to significant decrease in fractional shortening, and significant increases in left ventricular end-systolic diameter and volume. Treatment of adenylyl cyclase activator (forskolin analogue) normalized the depressed cardiac function. Resting cardiac function returned to normal after reversing mutant expression. Four-day survival rate of transverse-aortic constricted hErbB-1-mut mice was only 20% compared to 100% in controls. Conclusion: These observations indicate that blockade of cardiac ErbB-1 signaling leads to blockade of ErbB-2 signaling and together they result in cardiac dysfunction.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Barrick, R. B. Roberts, M. Rojas, N. M. Rajamannan, C. B. Suitt, K. D. O'Brien, S. S. Smyth, and D. W. Threadgill
Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H65 - H75.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.